Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01151696Phase 4Completed
Phase 4, randomised, double-blind trial in acute pain and anxiety disorder comparing Hydroxyzine with Placebo (2 arms). Primary endpoint: Percentage of patients with pain relief (NRS score of 3/10 or lower). Started May 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01151696.